Regulus Therapeutics (NASDAQ:RGLS)

CAPS Rating: 2 out of 5

Recs

0
Player Avatar pchop123 (78.31) Submitted: 4/4/2013 10:50:51 AM : Underperform Start Price: $6.61 RGLS Score: -5.15

Dropping back to reality

Featured Broker Partners


Advertisement